Trial Profile

ARDIS-2

Planning
Phase of Trial: Phase III

Latest Information Update: 18 Jul 2008

At a glance

  • Drugs R-verapamil (Primary)
  • Indications Irritable bowel syndrome
  • Focus Registrational; Therapeutic Use
  • Acronyms ARDIS-2
  • Sponsors AGI Therapeutics
  • Most Recent Events

    • 18 Jul 2008 This trial is expected to commence as soon as results of the ARDIS-1 trial are available next year.
    • 02 Oct 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top